ND3 USE OF GROUP-BASED TRAJECTORY MODELING TO IDENTIFY ADHERENCE CLUSTERS IN PATIENTS WITH MULTIPLE SCLEROSIS NEWLY-INITIATING ONCE- OR TWICE-DAILY ORAL DISEASE-MODIFYING DRUGS

To use group-based trajectory modeling (GBTM) to identify clusters of patients with multiple sclerosis (MS) with similar patterns of adherence to once- or twice-daily oral disease-modifying drugs (DMDs) over time. Eligibility criteria for this IQVIA™ RWD Adjudicated Claims - US data study were: ≥2 MS diagnoses (ICD-9 CM code 340.xx and ICD-10 CM code G35) between 7/1/2013–12/31/2016, ≥1 once-/twice-daily oral DMD claim between...